logo

For the Inventor, By the Inventor

Cape Town, South Africa

Stefan Barth

This inventor holds 18 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Immunotherapy Innovations. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., University of Cape Town, Rheinisch-Westfaelische Technische Hochschule Aachen. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Barth. Retrieved from https://idiyas.com/inventor/stefan-barth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 44.4

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Jena, DE (2013)
  • Roetgen, DE (2006 - 2015)
  • Aachen, DE (2014 - 2018)
  • Munich, DE (2015 - 2018)
  • Cape Town, ZA (2019 - 2021)
  • Green Point, ZA (2023)

Company Filing History:

goldMedal13 out of 4,926 
 
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.
 patents
silverMedal3 out of 94 
 
University of Cape Town
 patents
bronzeMedal2 out of 16 
 
Rheinisch-Westfaelische Technische Hochschule Aachen
 patents
4. 1 out of 6 
 
Bitop Ag
 patents
5. 1 out of 1 
 
Pharmed Artis Gmbh
 patent
6. 1 out of 7 
 
Rheinisch-Westfalische Technische Hochschule Aachen
 patents
7. 1 out of 9 
 
Technische Universitat Ilmenau
 patents
where one patent can have more than one assignee

Years Active: 2006-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Fusion Proteins
Photoimmuno-Theranostics
Cytotoxic Complex
Antibodies
Immunoproteases
Granzyme B
Photodynamic Therapy
Monoclonal Antibody
Immunokinases
Immuno-RNA-Constructs
Pharmaceutical Formulation
Silicon-Ceramic Composite
18 patents (USPTO):Explore Patents
1. 11572547 - Fusion proteins for the detection of apoptosis (2023-02-07),
2. 11124574 - Specific photoimmuno-theranostics for detection and elimination of skin cancer cells (2021-09-21),
3. 10668147 - Anti-CD89 cytotoxic complex (2020-06-02),
4. 10577412 - Anti-plasmodium parasite antibodies (2020-03-03),
5. 10344082 - Anti-parasitic complexes (2019-07-09),
6. 10246500 - Human cytolytic fusion proteins (2019-04-02),
7. 10072093 - Fusion protein to target and treat acute myeloid leukemia cells (2018-09-11),
8. 9944706 - Immunoproteases (2018-04-17),
9. 9872904 - Photoimmunoconjugates for use in photodynamic therapy (2018-01-23),
10. 9695239 - Microtubule-modifying compound (2017-07-04),
11. 9611318 - Anti-plasmodium parasite antibodies (2017-04-04),
12. 9528101 - Granzyme B protease variants (2016-12-27),
13. 9079963 - Monoclonal antibody for the detection of SNAP/CLIP tag (2015-07-14),
14. 9045739 - Immunokinases (2015-06-02),
15. 8829178 - Immuno-RNA-constructs (2014-09-09),

Title: The Innovative Journey of Stefan Barth

Introduction: Stefan Barth, a visionary inventor hailing from Cape Town, South Africa, has made significant contributions to the world of technology and innovation.

Latest Patents: Stefan Barth's latest patents include groundbreaking advancements in renewable energy technology, smart home automation systems, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Stefan Barth has established himself as a pioneer in the field of green technology, holding multiple patents that have revolutionized the way we approach environmental sustainability.

Collaborations: Throughout his career, Stefan Barth has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His partnerships have led to the development of cutting-edge products that have had a lasting impact on society.

Conclusion: Stefan Barth's passion for innovation and commitment to creating a more sustainable future have solidified his reputation as a trailblazer in the world of technology. His work continues to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…